Funding

Cancer treatment biotech AdvanCell injects $178 million Series C

- February 13, 2025 2 MIN READ

Sydney clinical-stage radiopharmaceutical startup AdvanCell, which is developing innovative cancer therapeutics, has raised US$112 million (A$178m) in a Series C. The round was co-led by US-UK fund SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis. Additional support came from existing investor Morningside, alongside new investors Tenmile, Brandon Capital, and others. Founded in June 2019, AdvanCell was… Read more »

Richard Boyd, Prof Alan Trounson and Dr Ian Nisbet
Funding

Biotech startup Cartherics doses up on $15 million raise for cancer treatment trials

- October 2, 2024 2 MIN READ

Melbourne biotech startup Cartherics has raised $15 million as it looks to begin trials of its cell therapy product for ovarian cancer. Cartherics, founded in 2015 by Alan Trounson, Bob Moses, and doctors Richard Boyd, Ian Nisbet and Peter Hudson, is developing immune cell therapies to treat cancer and other diseases. The startup previously raised $26… Read more »

R&D, science, man looking in microscope
Other tech

Andrew Forrest’s Minderoo Foundation backs $5.4 million raise for cancer biotech startup

- September 5, 2021 2 MIN READ

A biotech startup focused on treating cancer has raised $5.4 million, led by mining billionaire Andrew Forrest’s Minderoo Foundation. Adelaide-based Carina Biotech will use the cash injection to develop its “CAR-T” cell therapies to treat cancers such as colorectal cancer, which is the deadliest cancer for 25-34-year-old Australians. Carina’s founding shareholders, board and management also… Read more »